Equity in telehealth abortion care study
Part of Women’s health & pregnancy clinical trials.
This study looks at how telehealth and in-person medication abortion care work for patients. It aims to find ways to make care fairer and more accessible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently or about to get medication abortion care
- You are receiving care either in person or through telehealth
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a rapid blood test can replace ultrasound for women who want a very early medical abortion (before 6 weeks). It aims to make care simpler and faster.
This study compares video counseling (telemedicine) to standard in-person counseling for people seeking an abortion. It aims to see if telemedicine is a good option for discussing birth control afterward.
This study tests using telemedicine (phone or video visits) to provide medication abortion pills to women in Ecuador. It aims to see if this approach is safe and effective for early pregnancy (up to 12 weeks), making abortion care more accessible.
This study tests if getting contraceptive advice through a video call works as well as an in-person visit. It is for women who want to prevent pregnancy and do not plan to get pregnant in the next 6 months.
This study tests a telehealth program to support pregnant women through a 'multi-component optional model.' It is designed for women who are generally healthy and want extra help during pregnancy from the comfort of home.
This trial tests whether a home monitoring device linked to a telehealth platform can safely reduce the number of in-person fetal nonstress tests (NSTs) needed for pregnant people with certain conditions. It may help you by offering more convenient monitoring between 32 and 40 weeks of pregnancy.
Hear when a new Abortion in First Trimester trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.